Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
HitGen has successfully completed a three-year collaboration with MTPC to discover novel hit compounds for multiple drug targets 2022-02-25 10:00
Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer 2022-02-24 13:34
Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China 2022-02-24 10:32
Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement 2022-02-23 23:00
SyMap Medical Ltd Completed Enrollment in SMART Study for the Treatment of Uncontrolled Hypertension 2022-02-23 21:00
Simcere Pharma (2096.HK) Announces a Positive Profit Alert 2022-02-23 16:22
InnoCare Announces Dosing of First Patient in Phase II Clinical Trial Using Orelabrutinib for the Treatment of ITP 2022-02-22 17:09
111 to Announce Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results on March 17, 2022 - Conference Call to Follow 2022-02-22 16:38
HanAll Biopharma Appoints Almira Chabi as Chief Medical Officer and Chief Development Officer 2022-02-21 22:00
Daewoong Pharmaceutical Posts Record Annual Revenue in 2021, with Export Growth of Nabota and New Drug Development 2022-02-21 22:00
Adlai Nortye Announces Publication of Preclinical Research of AN3025 (anti-hTNFR2)in Frontiers in Immunology 2022-02-21 21:00
Keymed Bio Joins Hang Seng Family of Indexes 2022-02-18 22:10
TransThera Announces that the IND Application of TT-01488, a Non-covalent Reversible BTK Inhibitor, for the Treatment of B-Cell Lymphomas has been Approved by the FDA in the US and Officially Accepted by the NMPA in China 2022-02-18 22:00
PolyActiva Announces Positive Phase IIa Trial Results in Low Dose Cohort for PA5108 Ocular Implant with Prezia™ Sustained Drug Delivery Technology 2022-02-18 08:19
Flat Medical joins the Stay Connected(R), the International Organization for Safer Neuraxial Anesthesia 2022-02-17 21:00
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs 2022-02-16 20:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team 2022-02-15 21:00
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases 2022-02-15 15:05
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent 2022-02-14 08:25
Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results 2022-02-12 06:05
1 84 85 86 87 88 165